K. Ganesh Kumar, et.al., Adropin deficiency is associated with increased adiposity and insulin resistance., Obesity (Silver Spring, Md.), 2012, 20

http://rdf.ncbi.nlm.nih.gov/pubmed/22318315

K. Ganesh Kumar, et.al., Adropin deficiency is associated with increased adiposity and insulin resistance., Obesity (Silver Spring, Md.), 2012, 20

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Enho<tm1Butl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5781009
• Enho<tm1.1Butl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5781010

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• impaired glucose tolerance_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0005293B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• abnormal lipid metabolism_Enho<tm1.1Butl>/Enho<+>
  http://metadb.riken.jp/0013245B6CgEnhotm11ButlEnhotm11ButlEnhoEnhotm11ButlEnho
• hypoactivity_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0001402B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• abnormal lipid metabolism_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0013245B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• insulin resistance_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0005331B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• increased circulating triglyceride level_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0001552B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• impaired glucose tolerance_Enho<tm1.1Butl>/Enho<+>
  http://metadb.riken.jp/0005293B6CgEnhotm11ButlEnhotm11ButlEnhoEnhotm11ButlEnho
• increased body weight_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0001260B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• preweaning lethality, incomplete penetrance_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0011110B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• increased circulating insulin level_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0002079B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• increased body fat mass_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0014142B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• increased fasted circulating glucose level_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0013279B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• increased percent body fat/body weight_Enho<tm1.1Butl>/Enho<+>
  http://metadb.riken.jp/0005458B6CgEnhotm11ButlEnhotm11ButlEnhoEnhotm11ButlEnho
• increased liver triglyceride level_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0009355B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• hepatic steatosis_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0002628B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• preweaning lethality, incomplete penetrance_Enho<tm1.1Butl>/Enho<+>
  http://metadb.riken.jp/0011110B6CgEnhotm11ButlEnhotm11ButlEnhoEnhotm11ButlEnho
• increased liver triglyceride level_Enho<tm1.1Butl>/Enho<+>
  http://metadb.riken.jp/0009355B6CgEnhotm11ButlEnhotm11ButlEnhoEnhotm11ButlEnho
• increased percent body fat/body weight_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0005458B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• decreased muscle cell glucose uptake_Enho<tm1.1Butl>/Enho<tm1.1Butl>
  http://metadb.riken.jp/0030022B6CgEnhotm11ButlEnhotm11ButlEnhotm11ButlEnhotm11Butl
• hepatic steatosis_Enho<tm1.1Butl>/Enho<+>
  http://metadb.riken.jp/0002628B6CgEnhotm11ButlEnhotm11ButlEnhoEnhotm11ButlEnho

class

http://purl.org/net/cito/citesAsAuthority

• Enho<tm1Butl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5781009
• Enho<tm1.1Butl>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5781010